leupeptin has been researched along with Carcinoma, Ehrlich Tumor in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyagi, T; Hayashi, H; Hori, M; Moriya, Y; Nagai, M; Otani, T; Sakata, N; Tsuchiya, KS | 1 |
| Nishimura, C; Nishimura, T; Suzuki, H; Tanaka, N | 1 |
| Hara, T; Kato, Y; Umemoto, N | 1 |
3 other study(ies) available for leupeptin and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Aminopeptidase activity of an antitumor antibiotic, C-1027.
Topics: Aminoglycosides; Aminopeptidases; Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Apoproteins; Carcinoma, Ehrlich Tumor; Cell Survival; DNA, Neoplasm; Enediynes; Leucine; Leupeptins; Microsomes; Oligopeptides; Peptides; Proteins; Substrate Specificity; Swine; Tumor Cells, Cultured; Ultraviolet Rays | 1992 |
Potentiation of the cytotoxicity of peplomycin against Ehrlich ascites carcinoma by bleomycin hydrolase inhibitors.
Topics: Animals; Bleomycin; Carcinoma, Ehrlich Tumor; Cell Survival; Cysteine Endopeptidases; Drug Synergism; Female; Glycoside Hydrolases; Leucine; Leupeptins; Mice; Oligopeptides; Peplomycin | 1987 |
Cytotoxicities of two disulfide-bond-linked conjugates of methotrexate with monoclonal anti-MM46 antibody.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Ehrlich Tumor; Complement System Proteins; Cytotoxicity, Immunologic; Disulfides; Folic Acid Antagonists; Immunotoxins; Leupeptins; Methotrexate; Mice; Mice, Inbred C3H; Sulfhydryl Compounds; Thiamine Pyrophosphate | 1989 |